title: Identification of glutathione S-transferase omega 1 (GSTO1) protein as a novel tumor-associated antigen and its autoantibody in human esophageal squamous cell carcinoma.
abstract: Esophageal squamous cell carcinoma (ESCC) is the main form of esophageal malignancy. The approach for early diagnosis of this malignancy is very limited. In the present study, we first evaluated glutathione S-transferase omega 1 (GSTO1), a protein related to metabolism, as a tumor-associated antigen in ESCC, and we also evaluated its autoantibody as a potential biomarker in early detection of ESCC. First, immunohistochemistry (IHC) analysis of GSTO1 protein expression in esophageal tissues showed that the percentage of positive staining of GSTO1 in ESCC tissues was 87.5% while there was no positive staining in adjacent tissues or normal tissues, indicating that overexpression of GSTO1 is closely related to ESCC. Then, enzyme-linked immunosorbent assay (ELISA) showed that the frequency of detectable autoantibody against GSTO1 in patients' sera totals 44.8%. In contrast, the frequency of detectable autoantibody was only 6.7% in normal human sera (p < 0.01). To further evaluate our ELISA results, western blotting and immunofluorescence assay were also performed. The results were consistent with the data from ELISA. In conclusion, the current study has demonstrated that GSTO1 protein is overexpressed in ESCC and can induce a detectable autoantibody response, which may serve as a potential biomarker in the early detection of ESCC.
authors.affiliation: Department of Biological Sciences, The University of Texas at El Paso, El Paso, TX, 79968, USA.
authors.forename: Yang
authors.initials: Y
authors.lastname: Li
authors.forename: Qi
authors.initials: Q
authors.lastname: Zhang
authors.forename: Bo
authors.initials: B
authors.lastname: Peng
authors.forename: Qing
authors.initials: Q
authors.lastname: Shao
authors.forename: Wei
authors.initials: W
authors.lastname: Qian
authors.forename: Jian-Ying
authors.initials: JY
authors.lastname: Zhang
mesh_terms: D000951:Antigens, Neoplasm / Q000276:immunology*; D001323:Autoantibodies / Q000097:blood*; D014408:Biomarkers, Tumor / Q000097:blood*; D015153:Blotting, Western; D002294:Carcinoma, Squamous Cell / Q000276:immunology* / Q000473:pathology; D016022:Case-Control Studies; D004797:Enzyme-Linked Immunosorbent Assay; D004938:Esophageal Neoplasms / Q000276:immunology* / Q000473:pathology; D004947:Esophagus / Q000378:metabolism; D005455:Fluorescent Antibody Technique; D005500:Follow-Up Studies; D005982:Glutathione Transferase / Q000097:blood*; D006801:Humans; D007124:Immunoenzyme Techniques; D060787:Neoplasm Grading; D011379:Prognosis
chemical_list: D000951:Antigens, Neoplasm; D001323:Autoantibodies; D014408:Biomarkers, Tumor; C490476:GSTO1 protein, human; D005982:Glutathione Transferase
references.citation: J Biol Chem. 2001 Feb 2;276(5):3319-23
references.pmid: 11035031
references.citation: J Surg Oncol. 2011 Aug 1;104(2):176-80
references.pmid: 21538356
references.citation: Cancer Res. 2000 Apr 1;60(7):1777-88
references.pmid: 10766157
references.citation: Free Radic Res. 2009 Aug;43(8):738-43
references.pmid: 19513904
references.citation: FASEB J. 2008 Feb;22(2):343-54
references.pmid: 17901115
references.citation: J Biol Chem. 2000 Aug 11;275(32):24798-806
references.pmid: 10783391
references.citation: J Cancer Res Clin Oncol. 2009 May;135(5):673-8
references.pmid: 18941778
references.citation: Mol Immunol. 2002 May;38(12-13):981-7
references.pmid: 12009577
references.citation: Hum Mol Genet. 2003 Dec 15;12(24):3259-67
references.pmid: 14570706
references.citation: Oncol Rep. 2009 Feb;21(2):283-7
references.pmid: 19148497
references.citation: Stroke. 2007 Oct;38(10):2847-50
references.pmid: 17717316
references.citation: J Biol Chem. 1999 Feb 19;274(8):5131-7
references.pmid: 9988762
references.citation: J Gastroenterol Hepatol. 2009 May;24(5):729-35
references.pmid: 19646015
references.citation: Mol Biol Rep. 2009 Apr;36(4):781-4
references.pmid: 18398695
references.citation: Hepatobiliary Pancreat Dis Int. 2009 Apr;8(2):193-200
references.pmid: 19357035
references.citation: Diabetes. 2005 Dec;54 Suppl 2:S52-61
references.pmid: 16306341
references.citation: Methods Enzymol. 1997;279:30-5
references.pmid: 9211254
references.citation: J Proteome Res. 2011 Jun 3;10(6):2863-72
references.pmid: 21517111
references.citation: J Proteome Res. 2007 Feb;6(2):772-80
references.pmid: 17269733
references.citation: Tumour Biol. 2014 Mar;35(3):2661-7
references.pmid: 24399648
references.citation: Expert Rev Mol Diagn. 2010 Apr;10(3):321-8
references.pmid: 20370589
references.citation: Respir Res. 2007 Jul 06;8:48
references.pmid: 17617905
references.citation: Carcinogenesis. 2010 May;31(5):804-11
references.pmid: 20106899
references.citation: BMC Cancer. 2014 Feb 18;14:103
references.pmid: 24548688
references.citation: Neurobiol Aging. 2006 Aug;27(8):1087-93
references.pmid: 15985314
references.citation: J Histochem Cytochem. 2001 Aug;49(8):983-7
references.pmid: 11457926
references.citation: J Thorac Dis. 2014 May;6 Suppl 3:S289-97
references.pmid: 24876933
references.citation: FEBS J. 2009 Dec;276(23):6880-904
references.pmid: 19860826
references.citation: Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2161-81
references.pmid: 24057574
references.citation: Gastroenterology. 2010 Apr;138(4):1297-301
references.pmid: 20080091
references.citation: Cancer Res. 1996 Nov 1;56(21):4917-21
references.pmid: 8895744
references.citation: Cancer Lett. 2009 Aug 18;281(1):8-23
references.pmid: 19091462
references.citation: Neurology. 2004 Dec 28;63(12):2255-60
references.pmid: 15623683
references.citation: Nutr J. 2011 Dec 20;10:137
references.pmid: 22185224
references.citation: Methods Enzymol. 2005;401:78-99
references.pmid: 16399380
references.citation: Am J Gastroenterol. 2014 Jan;109(1):36-45
references.pmid: 24296751
references.citation: Int J Cancer. 2005 Jan 20;113(3):456-63
references.pmid: 15455378
references.citation: Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1222-6
references.pmid: 14652285